Gilead Sciences Ltd, 280 High Holborn

Gilead Sciences Ltd is a pharmaceutical supplier whose public sector sales cover antiviral medicines for hepatitis C and HIV.

Gilead has won contracts with NHS England and NHS National Services Scotland. Most of its awards are for medical equipment and pharmaceuticals.

Gilead Sciences Ltd, 280 High Holborn is connected to 128 direct awards. Its largest procurement category by award volume is Medical equipments, pharmaceuticals and personal care products.

Recent contract awards to Gilead Sciences Ltd, 280 High Holborn

Browse public sector contract awards given to Gilead Sciences Ltd, 280 High Holborn. Select a contract to see contract details and award amount.

Showing 18 of 128 results

Gilead Sciences Ltd, 280 High Holborn trend analysis

Explore a comprehensive breakdown of Gilead Sciences Ltd, 280 High Holborn's contract history, including top procurement categories, award trends over time, and key buyer relationships.

Top procurement categories associated with Gilead Sciences Ltd, 280 High Holborn

The procurement categories Gilead Sciences Ltd, 280 High Holborn wins the most work in, ranked by award notices published over the last five years.

TitleCount
  1. Medical equipments, pharmaceuticals and personal care products
    45
  2. Business services: law, marketing, consulting, recruitment, printing and security
    1
  3. Health and social work services
    1

Gilead Sciences Ltd, 280 High Holborn awards over time

See Gilead Sciences Ltd, 280 High Holborn's contract awards over the last 5 years.

Buyers awarding contracts to Gilead Sciences Ltd, 280 High Holborn

The public sector organisations that have awarded Gilead Sciences Ltd, 280 High Holborn the most contracts. Ranked by award notices published in the last five years.

The public sector suppliers most searched for on Stotles, with the number of notices naming each one.

Want to research a competitor or partner?

From first signal to bid submission, Stotles turns procurement chaos into predictable pipeline.